SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Magainin Pharm (MAGN)
MAGN 8.890+2.2%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kech who wrote (84)10/21/1997 6:31:00 PM
From: Shlepper  Read Replies (1) of 233
 
Tom,

After accumulating Magainin for over 5 years, I'm growing a little weary. What's the hold up on the submission of the NDA for Cytolex? I'm a little less concerned about the watering down of the stock, though - if the stock goes off well, then that'll help us all, but if they can't move it, then watch out! There still aren't many shares floated, and the last time they did this, it did boost the stock price. The stock rebounded today from being down 1 to 1/4. That's a good sign. I'm still optimistic about the long term for the stock, although I thought there's be a good short term run up based on the imminent approval of Cytolex.

Good Luck,

Shep
Their squalamine is a great long term thing as well as their other new research, but they need to speed up the NDA process.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News